4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001209191-23-057049
Director sold 148,884 shares at an average $0.87 ($128,993)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ENGLEMAN EDGAR Director | 2023-11-29 | Sale | −22,674 | $0.91 | $20,543 | 1,929,628 | I: show line 1 in the form |
| ENGLEMAN EDGAR Director | 2023-11-30 | Sale | −108,145 | $0.86 | $92,799 | 1,821,483 | I: show line 2 in the form |
| ENGLEMAN EDGAR Director | 2023-11-29 | Sale | −3,131 | $0.91 | $2,837 | 266,456 | I: show line 3 in the form |
| ENGLEMAN EDGAR Director | 2023-11-30 | Sale | −14,934 | $0.86 | $12,815 | 251,522 | I: show line 4 in the form |
| Open-market sales · 148,884 sh · avg $0.87 · $128,993 | |||||||
Loading xslF345X05/doc4.xml…